| EPE1005 | Compounding factors that affected viral load scale-up and viral load coverage in Kenya, before and during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1006 | Identifying the drivers and influencers of COVID-19 vaccine hesitancy in Nigeria | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1007 | Delivering HIV pre-exposure prophylaxis to people who use drugs experiencing homelessness during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1008 | PrEP use behaviors and sexual health in China during COVID-19 lockdowns | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1009 | The effect of Covid-19 on HIV services at HIV-care clinics in Myanmar | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1010 | Changes in HIV service utilization and care outcomes during the first year of the COVID-19 pandemic in Central Africa IeDEA sites | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1011 | Implementation of person-centered strategies to improve reengagement in care in Mumbai, India | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| LBEPA01 | Large decrease in the proportion of newly diagnosed HIV-1 infections grouping in large clusters in Spain | E-poster | HIV virology |
| LBEPA02 | Immune responses to respiratory syncytial virus among HIV-exposed uninfected infants from the United States correlate with maternal inflammation during pregnancy | E-poster | Host immune responses, vaccines and immunotherapies |
| LBEPA03 | Polymorphonuclear myeloid-derived suppressor cells regulates immune reconstitution during HIV infection through PD-L1 and TGF-β signaling | E-poster | HIV pathogenesis |